Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Scientific Publications

Real-world efficacy and adverse events of frontline nilotinib in pediatric CML in chronic phase: A prospective multi center study from SCCCG(Plus)-CML 2023 (Fan Z et al. Cancer, December 2025)

Details

Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG(Plus)-CML 2023
Fan Z et al. Cancer, December 2025 – open access publication